Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network-Reference-Cited by-同舟云学术

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Published:2016-03-06 Issue:9 Volume:18 Page:1297-1303
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:NEUONC

Author:

Langner-Lemercier Sophie,Houillier Caroline,Soussain Carole,Ghesquières Hervé,Chinot Olivier,Taillandier Luc,Soubeyran Pierre,Lamy Thierry,Morschhauser Franck,Benouaich-Amiel Alexandra,Ahle Guido,Moles-Moreau Marie-Pierre,Moluçon-Chabrot Cécile,Bourquard Pascal,Damaj Ghandi,Jardin Fabrice,Larrieu Delphine,Gyan Emmanuel,Gressin Remy,Jaccard Arnaud,Choquet Sylvain,Brion Annie,Casasnovas Olivier,Colin Philippe,Reman Oumedaly,Tempescul Adrian,Marolleau Jean-Pierre,Fabbro Michel,Naudet Florian,Hoang-Xuan Khê,Houot Roch

Funder

Institut National du Cancer (INCa)

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/9/1297/17431034/now033.pdf

Reference25 articles.

1. French Brain Tumor DataBase: 5-Year Histological Results on 25 756 Cases

2. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

3. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors

4. Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy

5. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL);Bergner;Cochrane Database Syst Rev,2012

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole, Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS;Current Medicinal Chemistry;2024-10

2. Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020;Neuro-Oncology;2024-06-25

3. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-06

4. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up;HemaSphere;2024-06

5. The notable outcomes of modified thiotepa-based conditioning followed by autologous stem cell transplantation in primary central nervous system lymphomas: A real-life pilot study;2024-05-31